ライフサイエンスコーパス: thyroid disease

1 r autoimmune disorders, including autoimmune thyroid disease.

2 nd 18p11, showed association with autoimmune thyroid disease.

3 is a risk factor for developing symptomatic thyroid disease.

4 erapy, family cancer history, and history of thyroid disease.

5 bone mass, spine radiography, and history of thyroid disease.

6 AITD1, a susceptibility locus for autoimmune thyroid disease.

7 rtality occurs in both overt and subclinical thyroid disease.

8 associations between serum PBBs and PCBs and thyroid disease.

9 lation between fetal cell microchimerism and thyroid disease.

10 people and in individuals with a history of thyroid disease.

11 many normal individuals without evidence of thyroid disease.

12 une disorders, notably juvenile diabetes and thyroid disease.

13 abetics and 377 clinic patients assessed for thyroid disease.

14 enal anomalies, hypertension, and autoimmune thyroid disease.

15 strategy to study PTC using a mouse model of thyroid disease.

16 failure, high-arched palate, and autoimmune thyroid disease.

17 TC1 in the peripheral blood of patients with thyroid disease.

18 oid individuals as well as for patients with thyroid disease.

19 ation and edema in the setting of autoimmune thyroid disease.

20 c hypothyroidism, and 1.3% other/unspecified thyroid disease.

21 models) for a medically confirmed history of thyroid disease.

22 t was more common for neonates of women with thyroid disease.

23 tertiles, respectively) after adjusting for thyroid disease.

24 o best care for individuals with subclinical thyroid disease.

25 oduction, and reduces the risk of autoimmune thyroid disease.

26 for primary hypothyroidism, the most common thyroid disease.

27 patients with normal, benign, and malignant thyroid disease.

28 butes to the skin changes seen in autoimmune thyroid disease.

29 ases and were not restricted to inflammatory thyroid diseases.

30 ontrolling the initiation and progression of thyroid diseases.

31 I for diagnostic and therapeutic purposes in thyroid diseases.

32 hy, retinopathy of prematurity, and neonatal thyroid diseases.

33 t of 10,827 individuals screened for various thyroid diseases.

34 surement distinguished benign from malignant thyroid diseases.

35 Subject 2 developed autoimmune thyroid disease 1.6 years after transplantation.

36 ncrease in PBB-153 (0.43 ng/mL), the OR (any thyroid disease)=1.12; (95% CI: 0.83, 1.52) (n=105 cases

37 0 [4.4%]), diabetes mellitus (8 [1.7%]), and thyroid disease (8 [1.7%]).

38 32 (24.1%) of 133 patients were examined for thyroid disease after PET.

39 ariant also increased the risk of autoimmune thyroid disease (AITD) in the RA patients, whereas the F

40 nal centers are often detected in autoimmune thyroid disease (AITD), but the mechanisms underlying ly

41 Autoimmune thyroid disease (AITD), including Graves' disease (GD) a

42 s of ankylosing spondylitis (AS), autoimmune thyroid disease (AITD), multiple sclerosis (MS) and brea

43 shown to be strongly linked with autoimmune thyroid disease (AITD).

44 q22 in 81 sib pairs affected with autoimmune thyroid disease (AITD).

45 etween type 1A diabetes (T1D) and autoimmune thyroid disease (AITD).

46 natures conferred a high risk for autoimmune thyroid disease (AITD).

47 Autoimmune thyroid diseases (AITD) arise from complex interactions

48 The autoimmune thyroid diseases (AITD), Graves' disease and chronic lym

49 ss II variant conferring risk for autoimmune thyroid diseases (AITD).

50 Autoimmune thyroid diseases (AITDs) are highly prevalent, affecting

51 The autoimmune thyroid diseases (AITDs) include two related disorders,

52 The autoimmune thyroid diseases (AITDs), comprising Graves disease (GD)

53 n melanoma, other cancers, lung/liver/kidney/thyroid disease, alcohol/drug use, income/education, hem

54 n addition to fungicides, in the etiology of thyroid disease among female spouses enrolled in the Agr

55 A diagnosis of thyroid disease among patients with uveitis and respecti

56 ion test for patients who have no history of thyroid disease and have few or no signs or symptoms of

57 s is one of very few models where autoimmune thyroid disease and hypothyroidism develop in most mice

58 Thyroid disease and osteoporosis are common problems oft

59 MS patients had slightly higher rates of thyroid disease and pernicious anaemia than did controls

60 With this increasing interest in thyroid disease and pregnancy, a variety of important st

61 concurrent autoimmune diseases of autoimmune thyroid disease and SLE.

62 method for (131)I RAIU measurement in benign thyroid disease and suggests that reducing the administe

63 Patients with benign thyroid disease and thyroid cancer were treated to achie

64 dividuals with PBC have a high prevalence of thyroid disease and thyroid disease is reportedly more p

65 o support associations of PBBs and PCBs with thyroid disease and thyroid hormone levels.

66 To determine the association between thyroid disease and uveitis.

67 responsible for immune dysregulation in both thyroid disease and uveitis.

68 rinary medicine, particularly for diagnosing thyroid diseases and guiding corrective therapy.

69 ohepatitis; however, the association between thyroid diseases and hepatocellular carcinoma (HCC) in m

70 tment, but otherwise the association between thyroid diseases and neonatal morbidity is understudied.

71 were seen individually or in clusters in all thyroid diseases and were not restricted to inflammatory

72 plies to each autoimmune disease, autoimmune thyroid disease (and Graves' disease in particular) cont

73 current preterm delivery, including alcohol, thyroid disease, and depression.

74 r mice survive, but display marked dwarfism, thyroid disease, and female infertility.

75 Graves' disease (GD) is a common thyroid disease, and Graves ophthalmopathy(GO) is the mo

76 ease, inflammatory bowel disease, autoimmune thyroid disease, and juvenile rheumatoid arthritis.

77 n thrombosis, hepatitis C, renal impairment, thyroid disease, and liver disease from 2003 to 2013 was

78 TSHR is also a primary antigen in autoimmune thyroid disease, and some TSHR antibodies may activate t

79 ' disease, Hashimoto thyroiditis, autoimmune thyroid disease, and systemic lupus erythematosus (SLE).

80 vitamin D deficiency, female sex, substernal thyroid disease, and thyroid cancer, necessitating centr

81 A), systemic lupus erythematosus, autoimmune thyroid disease, and type 1 diabetes mellitus, all of wh

82 atitis C receiving IFNalpha develop clinical thyroid disease, and up to 40% were reported to develop

83 matoid arthritis, celiac disease, autoimmune thyroid diseases, and type 1 diabetes.

84 mber of deaths was small, and the underlying thyroid disease appeared to play a role.

85 ltrasound-based screening programs to detect thyroid disease are advised for patients and family memb

86 nefits of detecting and treating subclinical thyroid disease are not well established.

87 The cardiovascular signs and symptoms of thyroid disease are some of the most profound and clinic

88 iefly (131)I, the effects of which on benign thyroid diseases are largely unknown.

89 ith uveitis as the main outcome variable and thyroid disease as the main predictor variable, while ad

90 e for the increased female susceptibility to thyroid disease, at least on activation of the PI3K path

91 dent diabetes mellitus (IDDM) and autoimmune thyroid disease (ATD), share genetic risk factors.

92 assay on serum from patients with autoimmune thyroid disease (ATD).

93 s (a) four members with both candidiasis and thyroid disease, (b) five members, including one pair of

94 provide a molecular basis for understanding thyroid disease based on mutations of IYD.

95 th conditions (including physician-diagnosed thyroid disease), behaviors, and demographics.

96 Thyroid disease, breast disease and granulomatosis lung

97 by individuals with PTC, melanoma, or benign thyroid disease, but not by unaffected individuals.

98 test abnormalities that do not reflect true thyroid disease, but rather are a manifestation of secon

99 The skin is commonly affected in thyroid diseases, but the mechanism for this association

100 volume plays a key role in the treatment of thyroid diseases by radioactive iodine 131I.

101 many late effects (eg, second malignancies, thyroid disease, cardiovascular disease, and altered rep

102 on TECs during development of an autoimmune thyroid disease characterized by TEC hyperproliferation

103 mented water develop a slow onset autoimmune thyroid disease, characterized by thyrocyte epithelial c

104 re a prominent feature of the two autoimmune thyroid diseases, chronic lymphocytic (Hashimoto's) thyr

105 Accumulating evidence documents thyroid disease coexisting with connective tissue disord

106 study period, 29 (12.9%) had a diagnosis of thyroid disease, compared with 62 of 896 patients (6.9%)

107 type 1 diabetes mellitus and with autoimmune thyroid disease, confirming the findings of other invest

108 Moreover, thyroid disease could be accelerated in young NODCCR7(ko

109 Graves' disease (GD) is an autoimmune thyroid disease defined by the production of stimulating

110 rlipidemia, gastroesophageal reflux disease, thyroid disease, diabetes, osteoporosis) in the 12 month

111 in thyroid function and the consequences of thyroid disease during pregnancy has rapidly grown in th

112 Subclinical thyroid disease during pregnancy may be associated with

113 ticipants increases the risk of the forms of thyroid disease evaluated in this study.

114 otyped 77 affected sib-pairs with autoimmune thyroid disease for eight polymorphic markers spanning t

115 e known significant geographic variations of thyroid disease, generalizability of these findings is u

116 curate and informative websites dedicated to thyroid disease, given the large number of patients who

117 of 115,746 participants without a history of thyroid disease, >/=20 years of age, was recruited in Ta

118 i population control group, patients who had thyroid disease had a 1.7-fold (95% CI, 1.03-2.80; P = .

119 d from a database if they had no preexisting thyroid disease, had taken amiodarone for >/=6 months, a

120 These findings suggest that a history of thyroid disease has a weak to moderate association with

121 ect of environmental radioiodine exposure on thyroid disease has been well studied, little is known r

122 Familial clustering of autoimmune thyroid diseases has led to studies of their association

123 s (T1D), multiple sclerosis (MS), autoimmune thyroid disease (Hashimoto thyroiditis or Graves disease

124 dverse outcomes were chronic kidney disease, thyroid disease, hypercalcemia, weight gain, hypertensio

125 id conditions included autoimmune diagnoses (thyroid disease in 14.6%, diabetes mellitus in 11.1%, in

126 vance: Early identification and treatment of thyroid disease in children and adolescents is critical

127 There were 21 cases of thyroid disease in men [OR=0.69 (95% CI: 0.33); 1.44 for

128 They also assessed risk of thyroid disease in relation to ever use of herbicides, i

129 iation between fetal cell microchimerism and thyroid disease in women.

130 timation and received an HTDS evaluation for thyroid disease, including a thyroid ultrasound, physica

131 h of the evidence that untreated subclinical thyroid disease is associated with clinical symptoms and

132 Thyroid disease is common, and evidence of an associatio

133 Thyroid disease is common, and thyroidectomy is a mainst

134 e Study (HTDS) was conducted to determine if thyroid disease is increased among persons exposed as ch

135 ociation between organochlorine exposure and thyroid disease is increasing.

136 The prevalence of unsuspected thyroid disease is lowest in men and highest in older wo

137 Thyroid disease is more common in women than men, and po

138 It is well known that thyroid disease is more frequent in women than in men; h

139 ave a high prevalence of thyroid disease and thyroid disease is reportedly more prevalent near Superf

140 ent in fibroblasts from donors without known thyroid disease, is partially susceptible to neutralizat

141 inations of generalized vitiligo, autoimmune thyroid disease, latent autoimmune diabetes in adults, r

142 se nationwide data suggest a need for better thyroid disease management to reduce neonatal morbidity.

143 disorders: type 1 diabetes mellitus (n = 4), thyroid disease (n = 2), and vitiligo (n = 2).

144 d hormones were measured in a subset without thyroid disease (n=551).

145 Neither concomitant nonsurgical thyroid disease nor more stringent selection criteria (p

146 ortance of the recognition of the effects of thyroid disease on the heart also derives from the obser

147 candidiasis only, and (c) three members with thyroid disease only.

148 FT4 (free thyroxine) and gait, without known thyroid disease or dementia.

149 8), arthritis (OR, 1.44; 95% CI, 1.12-1.85), thyroid disease (OR, 1.43; 95% CI, 1.02-1.99), antihista

150 specially Sjogren's syndrome (P = 0.001) and thyroid disease (P = 0.012).

151 disease had a higher likelihood of previous thyroid disease, particularly either Graves' disease or

152 ial diagnoses, risks of progression to overt thyroid disease, potential effects on various health out

153 form of RP3, when expressed in patients with thyroid disease, presents an unusual altered self target

154 2p for chronic mucocutaneous candidiasis and thyroid disease, previously identified using a panel of

155 es were searched for articles on subclinical thyroid disease published between 1995 and 2002.

156 have indicated that patients with autoimmune thyroid disease recognize epitopes of Tg which are not u

157 atients were recruited from 8 hospital-based thyroid-disease referral centers in Italy between 2006 a

158 e rate, 2.7 [CI, 1.3 to 5.0]) and history of thyroid disease (relative rate, 1.7 [CI, 1.1 to 2.6]) we

159 The risk of thyroid disease resulting from prolonged environmental 1

160 er autoimmune diseases, including autoimmune thyroid disease, rheumatoid arthritis, and type I diabet

161 f the skin, nails, and mucous membranes) and thyroid disease segregate as an autosomal dominant trait

162 The consequences of subclinical thyroid disease (serum TSH 0.1-0.45 mIU/L or 4.5-10.0 mI

163 Clinically relevant thyroid disease should be assessed preoperatively and ma

164 ; and inclusion of heterogenous and changing thyroid disease states.

165 The Hanford Thyroid Disease Study (HTDS) was conducted to determine

166 Subclinical thyroid diseases--subclinical hyperthyroidism and subcli

167 important in order to avoid complications of thyroid disease such as cardiac arrhythmias.

168 nsion, coronary artery disease, uncontrolled thyroid disease, systemic inflammatory disease, diabetes

169 sk Force issued a guideline on screening for thyroid disease that included a systematic evidence revi

170 (cohorts 1 and 3) with documented autoimmune thyroid disease, the T allele frequency was higher than

171 These studies concern screening for thyroid disease, thyroid eye disease and treatment with

172 nto either organ-specific illnesses, such as thyroid disease, type 1 diabetes, and mysasthenia gravis

173 diabetes mellitus type 1, rheumatic disease, thyroid disease, vitiligo, alopecia areata and inflammat

174 ia, systemic lupus erythematosus, autoimmune thyroid disease, vitiligo, and myasthenia gravis.

175 alence of self-reported clinically diagnosed thyroid disease was 12.5%, and prevalence of hypothyroid

176 ring 2005-2006, and information on diagnosed thyroid disease was collected by questionnaire.

177 Thyroid disease was common (18% overall; 25% among women

178 Thyroid disease was determined based on International Cl

179 12,504 subjects for whom personal history of thyroid diseases was known.

180 Clinical findings related to thyroid disease were analyzed for those patients who com

181 women, all odds ratios (ORs) for PBB-153 and thyroid disease were positive for quintiles above the re

182 es for the care of the pregnant patient with thyroid disease were released by the Endocrine Society i

183 The data of 37 patients with benign thyroid diseases were assessed.

184 In conclusion, thyroid diseases were associated with increased neonatal

185 itis compared with patients who did not have thyroid disease when controlling for age, sex, race, smo

186 id not undergo any further investigation for thyroid disease, whereas 32 (24.1%) of 133 patients were

187 ble in the peripheral blood of patients with thyroid disease, which correlates with a diagnosis of ca

188 ients 65 years of age or older with no known thyroid disease who were recruited from primary care reg

189 Most persons found to have subclinical thyroid disease will have TSH values between 0.1 and 0.4

190 ignificance of the association of autoimmune thyroid disease with DTC is less clear.

191 assay methods, the association of autoimmune thyroid disease with DTC, the prognostic significance of

192 Data supporting associations of subclinical thyroid disease with symptoms or adverse clinical outcom